BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26225471)

  • 1. The interplay between GRP78 expression and Akt activation in human colon cancer cells under celecoxib treatment.
    Tian S; Chang W; Du H; Bai J; Sun Z; Zhang Q; Wang H; Zhu G; Tao K; Long Y
    Anticancer Drugs; 2015 Oct; 26(9):964-73. PubMed ID: 26225471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
    Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS
    J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells.
    Tsutsumi S; Namba T; Tanaka KI; Arai Y; Ishihara T; Aburaya M; Mima S; Hoshino T; Mizushima T
    Oncogene; 2006 Feb; 25(7):1018-29. PubMed ID: 16205636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Tongxinluo on Apoptosis of Rat Cardiac Microvascular Endothelial Cells].
    Wei G; Li HR; Liu HL; Yao B; Chen M; Liang JQ; Jia ZH; Wu YL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):709-17. PubMed ID: 27491231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells.
    Xia S; Zhao Y; Yu S; Zhang M
    Cancer Biother Radiopharm; 2010 Jun; 25(3):317-23. PubMed ID: 20578837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways.
    Beales IL; Ogunwobi O
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):140-9. PubMed ID: 16442704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation.
    Piplani H; Rana C; Vaish V; Vaiphei K; Sanyal SN
    Biochim Biophys Acta; 2013 Nov; 1830(11):5142-56. PubMed ID: 23872169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.
    Kucab JE; Lee C; Chen CS; Zhu J; Gilks CB; Cheang M; Huntsman D; Yorida E; Emerman J; Pollak M; Dunn SE
    Breast Cancer Res; 2005; 7(5):R796-807. PubMed ID: 16168126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.
    Wu T; Leng J; Han C; Demetris AJ
    Mol Cancer Ther; 2004 Mar; 3(3):299-307. PubMed ID: 15026550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells.
    Semba S; Itoh N; Ito M; Harada M; Yamakawa M
    Clin Cancer Res; 2002 Jun; 8(6):1957-63. PubMed ID: 12060641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells.
    Huang KH; Kuo KL; Chen SC; Weng TI; Chuang YT; Tsai YC; Pu YS; Chiang CK; Liu SH
    PLoS One; 2012; 7(3):e33615. PubMed ID: 22438966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum stress response as a possible mechanism of cyclooxygenase-2-independent anticancer effect of celecoxib.
    Cha W; Park SW; Kwon TK; Hah JH; Sung MW
    Anticancer Res; 2014 Apr; 34(4):1731-5. PubMed ID: 24692703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
    Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
    Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.
    Ying L; Zhu Z; Xu Z; He T; Li E; Guo Z; Liu F; Jiang C; Wang Q
    PLoS One; 2015; 10(6):e0129593. PubMed ID: 26115510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M; Esmaeili-Mahani S
    Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib regulates apoptosis and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells.
    Liu M; Li CM; Chen ZF; Ji R; Guo QH; Li Q; Zhang HL; Zhou YN
    Int J Mol Med; 2014 Jun; 33(6):1451-8. PubMed ID: 24676394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
    Vaish V; Sanyal SN
    Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.